WinRho® SDF

Products



WinRho® SDF [Rho (D) Immune Globulin (Human) for Injection]


WinRho® SDF, [Rho (D) Immune Globulin (Human) for Injection], Cangene’s flagship product, is sold worldwide and is available either as a liquid formulation or a freeze-dried powder. 

WinRho® SDF is known as an anti-D product and is approved for two distinct indications.

WinRho® SDF was developed in 1968 by renowned pediatric researchers, Drs. Bruce Chown and John (Jack) Bowman. These physicians gained global recognition as pioneers for treating hemolytic disease of the newborn. In appreciation of their achievements, both physicians were made Officers of the Order of Canada.

*Product Information based on Canadian Product Monograph


The following information is available in .pdf

Canadian Product Monographs:

English
French


For Canadian Healthcare Professionals
WinRho®SDF Safety Update
English / French

For Residents of Canada
WinRho®SDF Public Notification
English / French



WinRho® SDF Product Inquiries


Canada
Tel: 1-877-226-4363
Email: custsvc@ebsi.com  

International
Tel: 01 (204) 275-4178
Email: internationalsales@ebsi.com

Medical Affairs:

Tel: 1-800-768-2304
Email: medicalaffairs@ebsi.com



Manufactured and distributed by Cangene Corporation. WinRho SDF® and any and all Emergent BioSolutions Inc. brand, product, service and feature names, logos and slogans are trademarks or registered trademarks of Emergent BioSolutions Inc. or its subsidiaries in the United States or other countries. All rights reserved.